SERBP1 can prevent the degradation of MAD2L1 mRNA (the degradation rate decreases by 40%), leading to the up-regulation of MAD2L1 protein expression, which in turn activates the cell cycle checkpoint and promotes the rapid proliferation of breast cancer cells [9]. This evidence concerns the gene MAD2L1 and breast carcinoma.